跳至主要内容
临床试验/NCT05417659
NCT05417659已完成不适用

The Effect of Suppression of Adipose Lipolysis on GLP-1 and Energy Intake in Men and Women

University of Bath2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Difference in ad libitum energy intake

研究概览

简要总结

Obesity is the outcome of chronic excessive energy intake and reduced energy expenditure leading to energy imbalance. It is a risk factor for many preventable diseases such as metabolic disease and its consequences such as type 2 diabetes and cardiovascular disease. Sedentary adults have been shown to have an increased appetite in excess of energy requirements and adults who are more active are able to better regulate energy intake. It is thought that carbohydrate availability and specifically hepatic glycogen utilisation during exercise is a regulator of appetite. However, the majority of research so far does not support this theory, potentially due to research not examining the tissue-specific link between glycogen use and appetite. The aim of this study is to assess whether altering substrate utilisation during exercise by suppressing lipolysis influences GLP-1 levels and caloric intake post exercise. Additionally, the study will explore if there is a tissue specific link between substrate utilisation and post exercise energy intake and examine potential sex differences.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males aged 18-60 and premenopausal women
  • Physically active (at least 30 minutes of exercise 3 times a week)
  • Body mass index 18.0-30.0 kg·m-2

排除标准

  • Weight instability (>5kg change in body mass over last 6 months)
  • Restrained eater (e.g. limiting food intake, calorie counting)
  • Current smoker
  • Aversion or allergy to test meal foods
  • Pregnant or lactating
  • Amenorrhoea in women
  • Any medical condition or medication that could introduce bias into the study (e.g., diabetes, CVD, lipid or glucose metabolism altering medications)
  • Any cardiopulmonary condition prohibiting exercise testing
  • Any contraindication to niacin or aspirin (e.g., diabetes, gout, clotting disorders, allergy to non-steroidal anti-inflammatory drugs)

结局指标

主要结局

Difference in ad libitum energy intake

时间窗: 2 hours post exercise

Difference between ad libitum energy intake (kcal) post exercise between trials

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Louise Bradshaw

PhD Student

University of Bath

研究点 (2)

Loading locations...

相似试验